Worldwide Brain Aneurysm Treatment Market | Top Key Players Survey | Forecast to 2023

The Brain Aneurysm Treatment Market is growing with a rapid pace. According to a recent study report published by the Market Research Future, the Brain Aneurysm Treatment Market is booming and expected to gain prominence over the forecast period and is projected to grow a sound pace. The market is projected to demonstrate a sound growth by 2023, surpassing its previous growth records in terms of value with a sound CAGR during the anticipated period (2017-2023).

Brain aneurysm or cerebral aneurysm or intracranial aneurysm is a weak bulging spot on the wall of a brain artery. In this medical condition, blood flows within the artery starts pushing the thinned portion of the wall. Usually, unruptured brain aneurysm may not show any symptoms. However, large unruptured aneurysm may cause change in vision followed by pain above and behind an eye, drooping eyelid, severe headache, and many others. Individuals harbouring a brain aneurysm can be diagnosed by various techniques, such as Computed Tomography (CT), Computed Tomography Angiogram (CTA), Magnetic Resonance Angiography (MRA), cerebral angiogram, besides others.

Get a Premium Sample report at https://www.marketresearchfuture.com/sample_request/4561 .

Intracranial aneurysms is a leading cause of haemorrhagic stroke. According to a published in the Angiology journal, it was found that in U.K 10%-15% of patients with intracranial aneurysms die before reaching the hospital and of those who survive, 46% develop some form of disability, 42% become dependent, and 12% are left severely impaired. Factors such as increasing healthcare funding by government bodies, advancement in surgical techniques, and high occurrence of high blood pressure are estimated to drive the market growth. However, high treatment cost and lack of awareness will restrain the market growth during the forecast period.

Medtronic Plc., Codman & Shurtleff, Inc., Raumedic AG, Vittamed, Sophysa Ltd., MicroPort Scientific Corporation, Orsan Medical Technologies, and Spiegelberg GmbH, Johnson & Johnson, Sophysa Ltd, HaiWeiKang, Head Sense Medical, InfraScan, Inc., Integra Life Sciences Corporation and others are some of the prominent players at the forefront of competition in the Brain Aneurysm Treatment Market and are profiled in MRFR Analysis. 

Brain Aneurysm Treatment Market - competitive analysis

Characterized by the presence of several well-established and small players, the Brain Aneurysm Treatment Market appears to be highly competitive and fragmented. International players are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

Browse Complete Report at https://www.marketresearchfuture.com/reports/brain-aneurysm-treatment-market-4561 .

In August, 2016- Medtronic Plc., the global leader in medical technology, completed their acquisition of HeartWare International, Inc., a leading innovator of less-invasive, miniaturized, mechanical circulatory support technologies (MCS) for treating patients with advanced heart failure. HeartWare became part of the Heart Failure business within the Medtronic Cardiac Rhythm and Heart Failure division. Under the terms of the transaction, each outstanding share of HeartWare common stock was converted into the right to receive USD 58.00 in cash.

In September, 2016- Johnson & Johnson announced that the company entered into a definitive agreement to acquire Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott Laboratories, for USD 4.325 billion in cash. AMO reported sales of USD 1.1 billion for 2015. The acquisition included ophthalmic products in three business segments: cataract surgery, laser refractive surgery and consumer eye health.

Brain Aneurysm Treatment Market - Regional Analysis

The Americas dominates the brain aneurysm treatment market. Rising in-screening process, increasing prevalence of brain aneurysm and high healthcare expenditure are the major drivers for market growth within the region. Furthermore, presence of major market players and developed economies like U.S. and Canada fuels the regional market growth. Followed by the Americas, Europe holds the second position in brain aneurysm treatment market. Government bodies for research & development followed by favourable reimbursement policies in healthcare drives the market within the region. Asia Pacific is estimated to be the fastest growing brain aneurysm treatment market owing to the huge patient pool and presence of developing countries like India and China.

About us

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

P: +1 646 845 9312

W: www.marketresearchfuture.com

sales@marketresearchfuture.com